Skip to main content

BARCLAYS PLC

Position in KRYS — Krystal Biotech, Inc.

CIK 312069 LONDON, X0

Position in KRYS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,763,737
+$1,480,147 QoQ
Shares Held
7,436
+49.6% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#142
of 419 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KRYS Over Time

Shares Held

Position Value (USD)

Derivatives in KRYS

reported options exposure · as of Jun 30, 2024
CallValue
$7,345,600
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. KRYS ranks #56 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KRYS

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,763,737 7,436
2026-03-31 $1,283,590 4,969
2025-12-31 $14,807,684 60,062
2025-09-30 $13,397,919 75,896
2025-06-30 $12,766,047 92,871
2025-03-31 $8,112,959 44,997
2024-12-31 $8,213,527 52,429
2024-09-30 $10,291,975 56,540
2024-06-30 $3,505,320 19,088
2024-06-30 $7,345,600 40,000
2024-03-31 $3,558,600 20,000
2024-03-31 $7,971,264 44,800
2024-03-31 $3,845,779 21,614
2023-12-31 $7,962,046 64,179
2023-09-30 $4,584,320 39,520
2023-06-30 $5,474,009 46,627
2023-03-31 $2,393,233 29,893
2022-12-31 $2,879,488 36,348
2022-09-30 $2,309,230 33,131
2022-06-30 $79,185 1,206
2022-03-31 $225,902 3,395
2021-12-31 $1,808,976 25,861
2021-09-30 $663,066 12,700
2021-06-30 $228,888 3,366
2021-03-31 $1,696,497 22,021
2020-12-31 $1,496,100 24,935
2020-09-30 $1,149,176 26,694
2020-06-30 $281,820 6,804
2020-03-31 $402,996 9,320